Institute of Hematology and Blood Transfusion

What Institute of Hematology and Blood Transfusion does

Institute of Hematology and Blood Transfusion (Instytut Hematologii i Transfuzjologii) is a Warsaw-headquartered medical research and clinical institution founded in 1951, operating with a workforce of 501-1,000 employees. Its mandate spans three integrated activities: hematology research, clinical trials, and hospital/clinical services, positioning it as a national reference center for blood diseases and transfusion medicine in Poland. The entity is classified as a government state entity (despite a conflicting "for_profit" flag in firmographic metadata) and is functionally aligned under the Polish Ministry of Health, indicating public-sector ownership and stewardship rather than commercial operation.

The institute's principal patient-facing digital asset is the Patient Portal (Portal Pacjenta), accessible via the institutional website at ihit.waw.pl, which serves as the primary web-based service for patient account creation, login, and information access. The underlying technology stack, product architecture, and module inventory are not disclosed in the available source material beyond the portal interface itself. No additional products, APIs, SDKs, or integrations are documented; no mobile application is indicated. The institute operates within Europe as its served market, with no global footprint claim and no documented geographic restrictions beyond its national remit.

The business model is consistent with a publicly funded healthcare and research institution rather than a commercial enterprise. Revenue mechanics are not disclosed, and there is no indication of commercial pricing, customer segments, go-to-market motion, or distribution channels. Funding rounds, investors, subsidiaries, and parent-company relationships are all absent from the source data. Operational status is confirmed as active. Given the data sparsity on commercial mechanics, the institution should be evaluated as a state-aligned specialty healthcare and research asset rather than a venture- or private-equity-style commercial target.

Name

Institute of Hematology and Blood Transfusion

Legal name

Instytut Hematologii i Transfuzjologii

Website

https://ihit.waw.pl

Company type

Private

Founded year

1951

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Specialty Hospital Services

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Blood and Organ Banks (621991), General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Medical Laboratories (8071), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Medical Hematology (Benign Hematology) (HLAKAFAA)

akta.pro secondary industries

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG), Hematology & Coagulation Laboratories (HLAFAMAC), Blood Bank/Transfusion Medicine LIS (HLACAMAE)

Keywords

• Hematology services
• Blood transfusion medicine
• Clinical research hematology
• Hospital blood disease treatment
• Transfusion diagnostics

Headquarters

HQ city

Warsaw

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Core offering

The Institute of Hematology and Blood Transfusion (Instytut Hematologii i Transfuzjologii) is a public medical and research institute in Warsaw, Poland, that provides specialized hospital services in hematology and blood transfusion, conducts clinical trials and research in hematology and transfusion medicine, and offers a Patient Portal (Portal Pacjenta) for patient access. It serves as a specialized referral center for blood-related diseases.

Product overview

Institute of Hematology and Blood Transfusion (Instytut Hematologii i Transfuzjologii) operates a Patient Portal (Portal Pacjenta) as its primary web-based service. The provided source content does not contain sufficient detail to enumerate specific products, modules, or the overall product architecture.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Broad incumbents

• Hôpital Saint-Louis (AP-HP): Paris-based specialty hospital historically focused on hematology, dermatology, and oncology. Comparable as a European specialty hospital with deep hematology heritage and integrated research and clinical services.
• National Heart, Lung, and Blood Institute (NHLBI): U.S. NIH institute supporting hematology and transfusion medicine research. Comparable as a public-sector, state-backed institution driving research and clinical standards in the same specialty.
• Karolinska University Hospital (Hematology Department): Swedish academic hospital with a major hematology and transfusion medicine department that combines research, clinical trials, and hospital services. Functions as a regional hub for complex hematology, similar to the institute's national role.

Direct peers

• Versiti: U.S. blood and transfusion medicine organization that combines blood collection, transfusion services, and hematology research. Comparable as an integrated blood and hematology research service organization.
• NHS Blood and Transplant: UK national blood and transplant service combining blood banking, transfusion medicine, and transplant-related hematology services. Comparable as a state-backed integrated blood and transplant organization.
• Sanquin Blood Supply: Dutch national blood bank and hematology-adjacent organization that combines blood collection, transfusion medicine, and hematology research. Directly comparable to the institute's combined transfusion and hematology research mission.
• German Red Cross Blood Donor Service (DRK Blutspendedienst): Major German blood banking and transfusion medicine network combining collection, processing, and transfusion-related research. Directly comparable to the institute's blood transfusion and laboratory functions.

Regional players

• Institute of Hematology, Chinese Academy of Medical Sciences: National hematology research and clinical institute in China. Comparable as a national-level hematology institute operating across research and clinical services, though geographically distinct.

Others

• European Blood and Marrow Transplant Society: Pan-European organization focused on hematology and transplantation research and standards. Comparable as a peer institution shaping the clinical and research environment for hematology centers.
• European Hematology Association: European professional society for hematology. Comparable as a thematic peer reflecting the institutional ecosystem in which the institute operates and benchmarks itself.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of Hematology and Blood Transfusion